MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Charts
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
AXS

AXS

AXIS Capital Holdings Limited

$99.14
-0.87
 (-0.87%)
Exchange:  NYSE
Market Cap:  7.234B
Shares Outstanding:  135.442M
Delayed data
Calculate AXS Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Financial Services
Industry:  Insurance – Diversified
   
CEO:  Vincent C. Tizzio
Full Time Employees:  1966
Address: 
29 Richmond Road
Pembroke
PE
HM 08
BM
Website:  https://www.axiscapital.com
AXIS Capital Holdings Ltd. engages in the provision of various insurance and reinsurance products and services. It operates through the Insurance and Reinsurance segments. The Insurance segment offers property, marine, terrorism, aviation, political risk, professional lines, liability, accident, and health insurance products. The Reinsurance segment offers non-life treaty reinsurance to insurance companies. The company was founded on December 9, 2002, and is headquartered in Pembroke, Bermuda.

Click to read more…

Revenue Segmentation

MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/04/30 — 1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue5,590,5196,018,8116,563,678
Gross Profit1,196,4721,789,7733,275,137
EBITDA542,4181,131,3101,348,668
Operating Income398,4451,008,2381,225,630
Net Income376,2921,081,7861,008,898

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets30,250,67232,520,29332,322,632
Total Liabilities24,987,47626,430,91425,966,197
Total Stockholders Equity5,263,1966,089,3796,356,435
Total Debt1,522,6051,488,1731,603,280
Cash and Cash Equivalents953,4762,143,4711,321,185

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow1,255,5591,844,813-40,932
Capital Expenditure-31,14400
Free Cash Flow1,255,5591,844,813-40,932
Net Income376,2921,081,7861,008,898
Net Change in Cash209,3321,679,636-1,742,436

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)8,113,745.157Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)8,507,555.019Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)8,329,584.983Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)1,147,780.787Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)1,203,489.635Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)1,178,313.765Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)1,112,607.711Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)1,202,413.712Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)1,157,510.712Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)962,714.693Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)1,009,441.147Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)988,324.589Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)14.770Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)15.170Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)14.040Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)3Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)4Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
5.973B  ?P/S
 (TTM)
: 
1.06
?Net Income
 (TTM)
: 
1.082B  ?P/E
 (TTM)
: 
6.18
?Enterprise Value
 (TTM)
: 
7.911B  ?EV/FCF
 (TTM)
: 
3.44
?Dividend Yield
 (TTM)
: 
1.78%  ?Payout Ratio
 (TTM)
: 
13.65%
?ROE
 (TTM)
: 
19.21%  ?ROIC
 (TTM)
: 
79.36%
?Net Debt
 (TTM)
: 
-1575448000  ?Debt/Equity
 (TTM)
: 
0.23
?P/B
 (TTM)
: 
1.12  ?Current Ratio
 (TTM)
: 
12.44

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
7.54Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

Strengths (preview)

  • Strong Financial Performance: AXIS Capital reported robust results in the Q2 2025 earnings call, with an annualized operating return on equity surpassing expectations. Key metrics such as revenue, net income, and operating income from recent income statements reflect consistent growth, positioning the company favorably within the insurance sector.
  • Healthy Cash Flow Generation: Cash flow statements indicate strong net cash provided by operating activities and positive free cash flow, supported by effective management of operating expenses and capital expenditure. This financial stability enhances AXS's ability to fund growth initiatives and return value to shareholders through dividends (as evidenced by a competitive dividend yield TTM).
  • Market Positioning: As highlighted in the company profile and earnings call summary, AXS benefits from a strategic focus on specialty insurance and reinsurance markets, which, combined with a solid market capitalization and operational scale (reflected in full-time employees and enterprise value TTM), provides a competitive edge in its industry.

Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.

Log in to continue

Log in with Full Access for the complete SWOT analysis.

Login — it's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates AXS intrinsic value between $245.77 – $318.69 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about AXS valuation

Is AXIS Capital Holdings Limited (AXS) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for AXIS Capital Holdings Limited (AXS) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is AXS a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether AXS trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is AXS’s P/E ratio?

You can see AXS’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for AXS?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is AXS a good long-term investment?

Whether AXS fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

AXS

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.87
MARKETSnap

Trading Metrics:

Open: 98.84   Previous Close: 100.01
Day Low: 98.44   Day High: 99.59
Year Low: 88.07   Year High: 119.99
Price Avg 50: 107.07   Price Avg 200: 102.98
Volume: 102611   Average Volume: 675142

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free

AXS full analysis

30/10/2025

Welcome to MARKETSNAP’s SWOT analysis for AXIS Capital Holdings Limited, also known by its ticker AXS. If you’re a long-term investor looking to dig into a solid player in the insurance and reinsurance space, you’ve come to the right place. Today, we’re breaking down the strengths, weaknesses, opportunities, and threats for AXIS Capital, a company that might not be a household name like some tech giants, but definitely packs a punch in its niche. So, grab a coffee, let’s dive…

Open MarketSnap Listen

Log in to continue

Log in to see the full analysis preview and audio links.

Login — it's free

See in Nexus

Relevant news

Bank of America Corp DE Reduces Stock Position in Axis Capital Holdings Limited $AXS
13-08-2026 03:39
Bank of America Corp DE Reduces Stock Position in Axis Capital Holdings Limited $AXS
AXS Lags Industry, Trades at a Discount: Here's How to Play the Stock
12-08-2026 14:41
AXS Lags Industry, Trades at a Discount: Here's How to Play the Stock
AXIS Capital Q2 Earnings Miss Estimates on Higher Catastrophe Losses
29-07-2026 14:11
AXIS Capital Q2 Earnings Miss Estimates on Higher Catastrophe Losses
Here's What Key Metrics Tell Us About Axis Capital (AXS) Q2 Earnings
28-07-2026 20:30
Here's What Key Metrics Tell Us About Axis Capital (AXS) Q2 Earnings
Will Axis Capital (AXS) Beat Estimates Again in Its Next Earnings Report?
16-04-2026 13:10
Will Axis Capital (AXS) Beat Estimates Again in Its Next Earnings Report?
Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance
16-07-2026 13:01
Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Philosophy
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlist & Portfolio Watchlist & Portfolio
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read